Introduction The case of Big Pharma “Big Pharma” has been facing issues with its controversial marketing, advertising, and sales techniques (Carroll, 2010). The industry’s off-label marketing practices, failure of full disclosure on bad news about products, and undue influence on doctor’s prescription decisions are just a few of the many unethical business practices that have come to light. These have resulted in many believing that companies in the gargantuan pharmaceutical industry have neglected, and perhaps even abandoned, science for salesmanship (Herper and Langreth, 2006). Although the public acknowledges value in the drugs available through pharmaceutical providers, the corporate social responsibilities (CSR) and business ethicality of the industry has been compromised and questioned (Gorrie and Santoro, 2005). Furthermore, the increasing complicity and costs of health care have only served to add strain to the public’s ability to empathise with criticism targeting the industry.
Doctors then would have to comply which can end up being more harmful to the patient. Another argument is that pharmaceuticals make little profit because new drugs cost so much to develop. Derek Lowe, a chemist, states that "Expenses [are] doing nothing but rising, and the success rate for drug discovery [is] going in the other direction" (para 5). By his quote, Lowe means that the development of a drug outweighs the cost of the drug, resulting in little profit. However, this case is on drugs that failed in the market.
The unethical behavior implications of KFC have affected its customers, suppliers and overall profit. Whereas Toyota violated the right of life and safety, tarnished brand image and incurred high costs due to fines. THE UNETHICAL DILEMMA OF KFC FRANCHISES AND THE IMPLICATIONS THAT THE ORGANISATION FACED Background KFC harms their famousness by directing abusive behaviour. Harland Sanders is the founder of
Fuld just forfeited the opportunity to take advantage of various solutions that would have been a major share for company’s losses. If they had behaved more ethically and prudently, Lehman bro’s story would have ended in different manner. •Lehman bro’s demise is unfortunate and not just because its collapse means it just came to an end of a Wall Street institution. The real tragedy was that there was lack of ethical behaviour of the company’s executives. They made unfruitful decisions.
Though the need for resources to be available may appear to be obvious, in a few examples managers have called for marketing research without appropriately understanding the measure of assets accessible including both monetary and human resources. Lack of assets can bring about dishonorable and wasteful execution of an advertising research venture. The results of such research frequently will be mistaken. Once more, if reserves are accessible to lead appropriate research however are lacking to actualize the consequence of the research, the marketing research is made useless. Also, the accessibility of an ability pool is a basic issue in choosing whether or not to direct broad showcasing research.
The relationship between the two is not quantifiable and it is difficult to determine whether a healthy culture truly causes high performance in a company (Denison & Mishra, 1989). However, there is a good qualitative analysis on this issue. Deal and Kennedy (1983) explains culture as a driver for the success or failure of the company. This would mean that depending on the positive or negative culture at the company, its growth might be potentially accelerated or stunted respectively. The collapse of Barings gives us some insight on how a negative culture could potentially ruin a company.
Hypothesis It is a hypothesis the primary reasons of the organization’s failure include the following: lack of leadership, lack of qualified compliance and risk management programs, inadequate control of internal legal documents and insufficient training of personnel. Research Significance and Purpose Research Significance The research on Ocwen Financial Corporation, is extremely valuable due to the difficulties the company is facing now, consequently, its necessary to expose the issues to improve profitability and gain back customers and investors’ confidence. A clear understanding of how to reverse and stop the lack of qualified compliance and risk management guidelines would not only benefit Ocwen’s customers, but also stockholders.
Nevertheless, the significance of crystallization processes has been underestimated in the pharmaceutical industry. Overall, unfavourable and inadequately understood physical properties are often at the root of many of the problems that delay new drug approvals by regulatory agencies; and manufacturing issues, stock-outs and product recalls are costly consequences of poor control over material properties [6,7]. Therefore the crystallization process is regarded with prime importance in drug formulation and design. This concept is being increasingly recognised by the pharmaceutical industry and driven under new regulatory directives encouraging quality by design [8-11]. Crystallization at the molecular level is a supramolecular process .
During mid twentieth century as huge advancements were being made in the field of health care, doctors and researchers often faced conflicts of interest between patient care and medical innovation. They were not bound by the same systems of rules, regulations, and checks that are in place today, which allowed these conflicts of interest to manifest themselves at an institutional level in some horrible ways during and after the second world war. When these questionable practices inevitably came to light, the public was shocked and disgusted. It was no longer a certainty that a doctor or researcher would always act in the best interest of their patient or subject. The medical institution could no longer be trusted to act ethically, and this meant that an outside influence was necessary in the previously exclusive field of medicine.
If the employees do not well-explained or convey the accurate information about the products, customers will misuse the product and cannot reach the satisfaction of using product. As the pharmaceuticals and chemicals products are science-based, it is difficult to understand the consumption and usage as the instruction illustrate by scientific term. The better strategic communication is critical in the company and it can be measured by the leading measure of the effectiveness to convey message to customer and information availability. Product or service error rate are the lagging